Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Osteosarcoma 1Intestinal Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Gemcitabine 6Irinotecan 4130-nm albumin-bound paclitaxel 4Cisplatin 3Albumin-Bound Paclitaxel 3napabucasin 2Leucovorin 2Imatinib Mesylate 2Everolimus 2Ascorbic Acid 2spartalizumab 1pralsetinib 1pembrolizumab 1dostarlimab 1copanlisib 1alectinib 1Ramucirumab 1Paclitaxel 1NUC-1031 1Levoleucovorin 1KRN-330 1HhAntag691 1Fluorouracil 1Cyclophosphamide 1Capecitabine 1Bevacizumab 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Digestive System Neoplasms × 5,10-methylenetetrahydrofolic acid × Clear all
NCT01681472 2020-09-25

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Isofol Medical AB

Phase 1/2 Completed
32 enrolled 52 charts
Gastrointestinal

Colonic Neoplasms, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡